The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Day One Biopharmaceuticals; Janssen; Novartis; Roche
Research Funding - BioMed Valley Discoveries (Inst)
Phase I results of the INFORM2 combination study of nivolumab and entinostat in children and adolescents: INFORM2 NivEnt.
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Melanie Heiss
No Relationships to Disclose
 
Ingrid Øra
Consulting or Advisory Role - Bayer
 
Andreas Beilken
No Relationships to Disclose
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst)
 
Nicholas G. Gottardo
Consulting or Advisory Role - Bayer; Day One Biopharmaceuticals
 
Dong-Anh Khuong-Quang
No Relationships to Disclose
 
Jordan Hansford
Stock and Other Ownership Interests - Anteotech
Consulting or Advisory Role - Bayer
 
Caroline Hutter
No Relationships to Disclose
 
Jasper Van der Lugt
No Relationships to Disclose
 
Anne Thorwarth
No Relationships to Disclose
 
Isabel Poschke
No Relationships to Disclose
 
Inga Harting
No Relationships to Disclose
 
Oliver Sedlaczek
No Relationships to Disclose
 
Pengbo Beck
No Relationships to Disclose
 
Angelika Freitag
No Relationships to Disclose
 
David T.W. Jones
No Relationships to Disclose
 
Natalie Jäger
No Relationships to Disclose
 
Annette Kopp-Schneider
No Relationships to Disclose
 
Olaf Witt
No Relationships to Disclose